Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-25-013485

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Randhawa Simrat CHIEF MEDICAL OFFICER 2025-02-03 Grant or award · Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X05/ownership.xml…